Literature DB >> 3132442

Single dose ciprofloxacin for the eradication of pharyngeal carriage of Neisseria meningitidis.

P N Gaunt1, B E Lambert.   

Abstract

Single dose oral ciprofloxacin was given to all personnel in a naval training establishment as part of the management of an outbreak of meningococcal meningitis. Two thousand one hundred personnel received the drug and Neisseria meningitidis was eradicated from the pharynx of 97% of 570 who were swabbed two to four days later. In a cohort of 277 personnel who were followed for up to nine weeks, pharyngeal carriage was eliminated from 93% of 104 carriers. The overall prevalence of carriage fell from 19% to less than 1.5% as a result of the use of ciprofloxacin. Few side effects were encountered, compliance was good and meningococci resistant to the antibiotic were not found after therapy. A single oral dose of ciprofloxacin 500 mg eliminates pharyngeal carriage of N. meningitidis effectively and has few adverse reactions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3132442     DOI: 10.1093/jac/21.4.489

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  17 in total

1.  Allergy associated with ciprofloxacin.

Authors:  P Burke; S R Burne
Journal:  BMJ       Date:  2000-03-11

2.  Use of fluoroquinolone antimicrobial agents by cardiovascular and cardiopulmonary surgeons.

Authors:  H C Neu
Journal:  Tex Heart Inst J       Date:  1990

Review 3.  Prospects for vaccine prevention of meningococcal infection.

Authors:  Lee H Harrison
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

4.  Secondary prevention of meningococcal disease. Ceftriaxone or ciprofloxacin should be considered as first line prophylaxis.

Authors:  M J Martin; N A Hutchinson; I J Eltringham; P Y Lee; K Birthistle
Journal:  BMJ       Date:  1996-06-15

5.  Secondary cases of meningococcal infection among close family and household contacts in England and Wales, 1984-7.

Authors:  R P Cooke; T Riordan; D M Jones; M J Painter
Journal:  BMJ       Date:  1989-03-04

6.  Evaluation of single-dose ciprofloxacin in the eradication of Neisseria meningitidis from nasopharyngeal carriers.

Authors:  D L Dworzack; C C Sanders; E A Horowitz; J M Allais; M Sookpranee; W E Sanders; F M Ferraro
Journal:  Antimicrob Agents Chemother       Date:  1988-11       Impact factor: 5.191

7.  First recorded outbreaks of meningococcal disease in the Israel Defence Force: three clusters due to serogroup C and the emergence of resistance to rifampicin.

Authors:  R Almog; C Block; M Gdalevich; B Lev; M Wiener; S Ashkenazi
Journal:  Infection       Date:  1994 Mar-Apr       Impact factor: 3.553

Review 8.  Guidelines for control of meningococcal disease. Laboratory Centre for Disease Control. Canadian Consensus Conference on Meningococcal Disease.

Authors: 
Journal:  CMAJ       Date:  1994-06-01       Impact factor: 8.262

9.  Use of single-dose ofloxacin to eradicate tonsillopharyngeal carriage of Neisseria meningitidis.

Authors:  O H Gilja; A Halstensen; A Digranes; H Mylvaganam; A Aksnes; E A Høiby
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

10.  Method To Detect Only Live Bacteria during PCR Amplification.

Authors:  Takashi Soejima; Ken-ichiro Iida; Tian Qin; Hiroaki Taniai; Masanori Seki; Shin-ichi Yoshida
Journal:  J Clin Microbiol       Date:  2008-04-30       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.